Peripheral T-Cell Reprogramming Characterized by Actin Remodeling and Suppressive Communication in Pembrolizumab-Resistant Lung Adenocarcinoma
Year: 2026
Type: article
Study design: Observational Study
Abstract: Resistance to PD-1 blockade remains a major challenge in lung adenocarcinoma, and the systemic immune mechanisms underlying therapeutic failure are not fully understood. Peripheral blood provides a minimally invasive window to monitor immune remodeling; however, single-cell-level characterization of T-cell alterations associated with pembrolizumab resistance is still limited. Peripheral blood samples from lung adenocarcinoma patients treated with pembrolizumab were collected and stratified into response (CR/PR, n = 3) and nonresponse (SD/PD, n = 4) groups according to RECIST 1.1. Single-cell RNA sequencing was performed to profile immune cell composition and transcriptional states. hdWGCNA was applied to identify response-associated co-expression modules, CellChat was used to intercellular communication, and Monocle2 was employed to explore inferred T-cell state relationships. A total of 91,576 high-quality cells were analyzed. In pooled summaries, patients in the nonresponse group showed a higher relative proportion of CD4+ Treg cells and a lower relative proportion of CD8+ naïve T cells. Network analysis identified 23 module-related DEGs enriched in cytoskeleton- and adhesion-related functional categories. Cell–cell communication analysis predicted increased communication potential, including TGF-β and MIF pathways, and increased adhesion-type interactions such as ADGRE5–CD55 and ITGB2–ICAM1. Pseudotime analysis showed variation in cytoskeleton-associated gene expression (ACTB, ACTG1, PFN1, and S100A family genes) along the inferred trajectory, indicating variation in cytoskeleton-related transcriptional states. These findings associate pembrolizumab nonresponse with altered peripheral T-cell composition, cytoskeleton- and adhesion-related transcriptional programs, and predicted intercellular interactions, generating hypotheses for future functional and clinical validation.
Authors: Wumiti Xiefukaiti(Formal analysis, Investigation, Writing – original draft), Aerzu Mijiti(Investigation, Methodology), Zi-Hang Wang(Data curation, Software, Visualization), Meng-Jia Li(Data curation, Software), Qing-Mei Zhu(Resources), Nadira Dolkun(Investigation, Resources), Lu-Feng Cheng(Conceptualization, Writing – review & editing), Xue-Jun Xiao(Conceptualization, Funding acquisition, Project administration, Supervision, Writing – review & editing)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: lung adenocarcinoma, anti-PD-1 therapy, T cell reprogramming, actin cytoskeleton remodeling, CD4+ regulatory T cells, naive CD8+ T cells, intercellular communication, TGF-beta signaling, MIF signaling, cytoskeletal genes, adhesion molecules, immune checkpoint inhibitor resistance, peripheral immune cells
Open Access status: gold
Estimated APC paid: $3,499
Funder: Xinjiang Medical University
OpenAlex ID: W7236706741
